| |
| |
| Nasal |
| RENAL FUNCTION TESTING |
| Child:
1-15 yr: 20 mcg and infants: 10 mcg. To be given as a single dose. |
| |
| Nasal |
| RENAL FUNCTION TESTING |
| Adult:
40 mcg as a single dose. |
| |
| Nasal |
| DIAGNOSIS OF DIABETES INSIPIDUS |
| Child:
20 mcg as a single dose. |
| |
| Nasal |
| DIAGNOSIS OF DIABETES INSIPIDUS |
| Adult:
20 mcg as a single dose. |
| |
| Nasal |
| CRANIAL DIABETES INSIPIDUS |
| Child:
3 mth-12 yr: 5-30 mcg daily. |
| |
| Nasal |
| CRANIAL DIABETES INSIPIDUS |
| Adult:
10-40 mcg daily as a single or divided doses |
| |
| Parenteral |
| RENAL FUNCTION TESTING |
| Child:
Infants: 0.4 mcg; children: 2 mcg. Dose to be given as SC or IM inj. |
| |
| Oral |
| CRANIAL DIABETES INSIPIDUS |
| Adult:
Initially, 100 mcg tid adjusted according to response. Maintenance: 100-200 mcg tid, up to 100-1200 mcg daily. |
| |
| Oral |
| PRIMARY NOCTURNAL ENURESIS |
| Adult:
200-400 mcg at bedtime. |
| |
| Oral |
| CRANIAL DIABETES INSIPIDUS |
| Child:
Initially, 100 mcg tid adjusted according to response. Maintenance: 100-200 mcg tid, up to 100-1200 mcg daily. |
| |
| Oral |
| PRIMARY NOCTURNAL ENURESIS |
| Child:
≥5 yr: 200-400 mcg at bedtime. |
| |
| Intravenous |
| TYPE I VON WILLEBRAND'S DISEASE |
| Adult:
0.3-0.4 mcg/kg by slow infusion over 15-30 min before surgery. |
| |
| Intravenous |
| TESTING OF FIBRINOLYTIC RESPONSE |
| Adult:
0.4 mcg/kg infused over 20 min. |
| |
| Intravenous |
| TESTING OF FIBRINOLYTIC RESPONSE |
| Child:
0.4 mcg/kg infused over 20 min. |
| |
| Parenteral |
| CRANIAL DIABETES INSIPIDUS |
| Adult:
1-4 mcg daily IM, SC or IV. |
| |
| Parenteral |
| CRANIAL DIABETES INSIPIDUS |
| Child:
0.4 mcg IM, SC, or IV. |
| |
| Parenteral |
| DIAGNOSIS OF DIABETES INSIPIDUS |
| Adult:
2 mcg as a single dose via SC/IM. |
| |
| Parenteral |
| DIAGNOSIS OF DIABETES INSIPIDUS |
| Child:
2 mcg SC/IM. |
| |
| Parenteral |
| RENAL FUNCTION TESTING |
| Adult:
2 mcg given as SC or IM inj. |
| |
| Nasal |
| PRIMARY NOCTURNAL ENURESIS |
| Adult:
20-40 mcg at bedtime. |
| |
| Nasal |
| PRIMARY NOCTURNAL ENURESIS |
| Child:
≥5 yr: 20-40 mcg at bedtime |
| |
| Nasal |
| NOCTURIA ASSOCIATED WITH MULTIPLE SCLEROSIS |
| Adult:
10-20 mcg at bedtime. |
| |
| Nasal |
| TYPE I VON WILLEBRAND'S DISEASE |
| Adult:
300 mcg; <50 kg: 150 mcg. Should be given within 2 hr before the surgery. |
